Growth and Safety Clinical Trial on a New Infant Formula.

Inclusion Criteria: * Healthy gestational term (≥ 37 wks; ≤ 41 wks and 6 days). * Birth weight of ≥ 2,500 g and ≤ 4,500 g. * Postnatal age ≤ 14 days. * Singleton. * Designated as healthy, that is no recognized diseases. * Weight, length, weight-for-length, and head circumference within ≥ 5th and ≤ 95th percentile for age-sex according to World Health Organization (WHO) growth standards (birth to 24 months). * Exclusive feeding and tolerating cow milk formula at time of enrollment. * Parent(s) or legal guardians are willing and able to feed the assigned formula as sole source of nutrition. * Parent(s) or legal guardians are willing and able to participate in anthropometric procedures. * Parent(s) or legal guardians have voluntarily signed and dated required participation forms, such as the ICF approved by an IRB. Exclusion Criteria: * An infant from a multiple birth, such as twin, triplet, or the like. * Personal or immediate family history of cow-milk protein allergy or intolerance. * Currently on any medication to treat growth failure or that may significantly impact growth. * Evidence of any anatomic and/or physiologic condition that would interfere with normal growth, development, or feeding, such as genetic, neurological, gastrointestinal, cardiac, pulmonary, hepatic, or renal. * A maternal history with known adverse effects on the fetus and/or the newborn infant, such as positive HIV, insulin-dependent diabetes, opioid exposure during pregnancy. * Enrolled in another clinical trial involving a drug, nutrition supplement, device, or intervention.